Results 211 to 220 of about 24,922 (273)

Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain

, 2007
Axel T. Brünger, Mark A. Breidenbach, Rongsheng Jin, Audrey Fischer, Jose S. Santos, M Montal   +5 more
openalex   +2 more sources

Research priorities in limb and task-specific dystonias [PDF]

, 2017
Altenmüller, Eckart, Alter, Katharine, Alterman, Ron L, Chen, Robert, Frucht, Steven, Furuya, Shinichi, Hallett, Mark, Jankovic, Joseph, Jinnah, H.A., Kimberley, Teresa J, Lungu, Codrin, Perlmutter, Joel S, Prudente, Cecilia N, Richardson, Sarah Pirio   +13 more
core   +2 more sources

Do female and male patients with cervical dystonia respond differently to long-term botulinum neurotoxin therapy? [PDF]

Front Neurol
Hefter H, Samadzadeh S, Moll M.
europepmc   +1 more source

Impact of molecular weight and serotype on botulinum neurotoxin oral toxicity and stability in simulated gastrointestinal tract conditions

, 2012
J. Adam Crawford, Jennifer Kronenberg, Jennifer L. Beare, Rebekah A. Starner, Angelo Scorpio, Sherry Kathleen Blight   +5 more
openalex   +1 more source

Transdermal Delivery of Botulinum Neurotoxin A: A Novel Formulation with Therapeutic Potential. [PDF]

Pharmaceutics
Kumar R, Singh BR.
europepmc   +1 more source

Correction: Epitope Characterization and Variable Region Sequence of F1-40, a High-Affinity Monoclonal Antibody to Botulinum Neurotoxin Type A (Hall Strain)

, 2009
Miles C. Scotcher, Jeffery A. McGarvey, Eric A. Johnson, Larry H. Stanker   +3 more
openalex   +1 more source

Therapeutic Modulation of the Nox2-Hv1-ROS Axis by Botulinum Neurotoxin A Confers Protection Against CoCl₂-Induced Retinal Hypoxic Injury. [PDF]

Int J Mol Sci
Lee HJ, Park M, Shin HA, Lew H.
europepmc   +1 more source

Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity. [PDF]

Toxins (Basel)
Milte R, Song J, Docking S, Ratcliffe J, Cameron ID, Crotty M, Ada L, English C, Lannin NA.   +8 more
europepmc   +1 more source

Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge. [PDF]

Mol Med
O'Brien SW, Gregg BM, Bollapragada A, McNutt PM.   +3 more
europepmc   +1 more source

Botulinum Neurotoxin Type A Combined with Platelet-Rich Plasma Promotes Hair Follicle Growth and Regeneration via STMN1 Modulation and Wnt/β-Catenin Pathway Activation. [PDF]

J Microbiol Biotechnol
Li J, Jia Z, Zhou Y, Gao L, Ma Y.
europepmc   +1 more source